nodes	percent_of_prediction	percent_of_DWPC	metapath
Liotrix—ALB—hematologic cancer	0.0891	0.512	CbGaD
Liotrix—ABCB1—hematologic cancer	0.0851	0.488	CbGaD
Liotrix—SLCO1A2—Chlorambucil—hematologic cancer	0.0504	0.114	CbGbCtD
Liotrix—SLCO4C1—Methotrexate—hematologic cancer	0.0373	0.0843	CbGbCtD
Liotrix—SLCO1C1—Methotrexate—hematologic cancer	0.0262	0.0592	CbGbCtD
Liotrix—SLC22A8—Mercaptopurine—hematologic cancer	0.024	0.0544	CbGbCtD
Liotrix—SLCO1A2—Prednisolone—hematologic cancer	0.0191	0.0431	CbGbCtD
Liotrix—SLCO1A2—Prednisone—hematologic cancer	0.018	0.0407	CbGbCtD
Liotrix—ABCB1—Lenalidomide—hematologic cancer	0.0164	0.0372	CbGbCtD
Liotrix—SLCO1B1—Irinotecan—hematologic cancer	0.0161	0.0364	CbGbCtD
Liotrix—CYP2C8—Bortezomib—hematologic cancer	0.0149	0.0337	CbGbCtD
Liotrix—SLCO1B3—Methotrexate—hematologic cancer	0.0146	0.0331	CbGbCtD
Liotrix—ALB—Imatinib—hematologic cancer	0.0141	0.0319	CbGbCtD
Liotrix—CYP2C8—Ifosfamide—hematologic cancer	0.0114	0.0258	CbGbCtD
Liotrix—SLCO1A2—Dexamethasone—hematologic cancer	0.0112	0.0254	CbGbCtD
Liotrix—CYP2C8—Nilotinib—hematologic cancer	0.00991	0.0224	CbGbCtD
Liotrix—ABCB1—Daunorubicin—hematologic cancer	0.00964	0.0218	CbGbCtD
Liotrix—ABCB1—Alitretinoin—hematologic cancer	0.00944	0.0213	CbGbCtD
Liotrix—ALB—Prednisone—hematologic cancer	0.0093	0.021	CbGbCtD
Liotrix—SLCO1A2—Methotrexate—hematologic cancer	0.00903	0.0204	CbGbCtD
Liotrix—ALB—Irinotecan—hematologic cancer	0.00881	0.0199	CbGbCtD
Liotrix—SLCO1B1—Methotrexate—hematologic cancer	0.00852	0.0193	CbGbCtD
Liotrix—SLC22A8—Methotrexate—hematologic cancer	0.00786	0.0178	CbGbCtD
Liotrix—ABCB1—Imatinib—hematologic cancer	0.00738	0.0167	CbGbCtD
Liotrix—ABCB1—Nilotinib—hematologic cancer	0.00671	0.0152	CbGbCtD
Liotrix—ABCB1—Vinorelbine—hematologic cancer	0.00665	0.015	CbGbCtD
Liotrix—ABCB1—Dasatinib—hematologic cancer	0.00593	0.0134	CbGbCtD
Liotrix—ABCB1—Mitoxantrone—hematologic cancer	0.00586	0.0132	CbGbCtD
Liotrix—CYP2C8—Etoposide—hematologic cancer	0.00546	0.0123	CbGbCtD
Liotrix—ABCB1—Betamethasone—hematologic cancer	0.00522	0.0118	CbGbCtD
Liotrix—ABCB1—Gemcitabine—hematologic cancer	0.00517	0.0117	CbGbCtD
Liotrix—ABCB1—Prednisolone—hematologic cancer	0.00515	0.0116	CbGbCtD
Liotrix—ABCB1—Prednisone—hematologic cancer	0.00486	0.011	CbGbCtD
Liotrix—ALB—Methotrexate—hematologic cancer	0.00466	0.0105	CbGbCtD
Liotrix—ABCB1—Irinotecan—hematologic cancer	0.00461	0.0104	CbGbCtD
Liotrix—CYP2C8—Dexamethasone—hematologic cancer	0.00449	0.0101	CbGbCtD
Liotrix—ABCB1—Vinblastine—hematologic cancer	0.0041	0.00927	CbGbCtD
Liotrix—ABCB1—Vincristine—hematologic cancer	0.00403	0.00911	CbGbCtD
Liotrix—ABCB1—Cisplatin—hematologic cancer	0.00376	0.0085	CbGbCtD
Liotrix—ABCB1—Etoposide—hematologic cancer	0.00369	0.00835	CbGbCtD
Liotrix—SERPINA7—hematopoietic system—hematologic cancer	0.00362	0.0655	CbGeAlD
Liotrix—ABCB1—Dexamethasone—hematologic cancer	0.00304	0.00687	CbGbCtD
Liotrix—ABCB1—Doxorubicin—hematologic cancer	0.00252	0.0057	CbGbCtD
Liotrix—ABCB1—Methotrexate—hematologic cancer	0.00244	0.00552	CbGbCtD
Liotrix—SERPINA7—blood—hematologic cancer	0.0024	0.0434	CbGeAlD
Liotrix—SERPINA7—bone marrow—hematologic cancer	0.00232	0.042	CbGeAlD
Liotrix—THRA—gonad—hematologic cancer	0.0017	0.0308	CbGeAlD
Liotrix—THRB—gonad—hematologic cancer	0.0017	0.0308	CbGeAlD
Liotrix—TTR—hematopoietic system—hematologic cancer	0.00166	0.0301	CbGeAlD
Liotrix—SLCO4C1—blood—hematologic cancer	0.00155	0.028	CbGeAlD
Liotrix—SLC10A1—gonad—hematologic cancer	0.0015	0.0272	CbGeAlD
Liotrix—SLCO4C1—bone marrow—hematologic cancer	0.0015	0.027	CbGeAlD
Liotrix—SLCO4C1—lung—hematologic cancer	0.00136	0.0245	CbGeAlD
Liotrix—SLCO1B3—lung—hematologic cancer	0.00132	0.0238	CbGeAlD
Liotrix—SLCO1B1—hematopoietic system—hematologic cancer	0.00131	0.0237	CbGeAlD
Liotrix—SLC16A10—hematopoietic system—hematologic cancer	0.00131	0.0236	CbGeAlD
Liotrix—THRA—lung—hematologic cancer	0.0013	0.0235	CbGeAlD
Liotrix—THRB—lung—hematologic cancer	0.0013	0.0235	CbGeAlD
Liotrix—THRA—testis—hematologic cancer	0.00123	0.0222	CbGeAlD
Liotrix—THRB—testis—hematologic cancer	0.00123	0.0222	CbGeAlD
Liotrix—SLC16A2—lung—hematologic cancer	0.00118	0.0213	CbGeAlD
Liotrix—SLC16A2—testis—hematologic cancer	0.00111	0.0201	CbGeAlD
Liotrix—TTR—blood—hematologic cancer	0.0011	0.0199	CbGeAlD
Liotrix—SLC10A1—testis—hematologic cancer	0.00108	0.0196	CbGeAlD
Liotrix—SLCO1A2—hematopoietic system—hematologic cancer	0.00107	0.0193	CbGeAlD
Liotrix—TTR—bone marrow—hematologic cancer	0.00107	0.0193	CbGeAlD
Liotrix—SLCO1C1—testis—hematologic cancer	0.00102	0.0184	CbGeAlD
Liotrix—SLC22A8—hematopoietic system—hematologic cancer	0.00102	0.0184	CbGeAlD
Liotrix—SLC16A10—gonad—hematologic cancer	0.000994	0.018	CbGeAlD
Liotrix—TTR—lung—hematologic cancer	0.000966	0.0175	CbGeAlD
Liotrix—TTR—testis—hematologic cancer	0.000912	0.0165	CbGeAlD
Liotrix—THRA—lymph node—hematologic cancer	0.000889	0.0161	CbGeAlD
Liotrix—THRB—lymph node—hematologic cancer	0.000889	0.0161	CbGeAlD
Liotrix—SLCO1B1—blood—hematologic cancer	0.000869	0.0157	CbGeAlD
Liotrix—SLC16A10—blood—hematologic cancer	0.000866	0.0157	CbGeAlD
Liotrix—SLCO4A1—lung—hematologic cancer	0.000866	0.0157	CbGeAlD
Liotrix—SLCO4A1—testis—hematologic cancer	0.000817	0.0148	CbGeAlD
Liotrix—SLC16A2—lymph node—hematologic cancer	0.000806	0.0146	CbGeAlD
Liotrix—SLC16A10—lung—hematologic cancer	0.000759	0.0137	CbGeAlD
Liotrix—CYP2C8—hematopoietic system—hematologic cancer	0.000746	0.0135	CbGeAlD
Liotrix—SLCO1C1—lymph node—hematologic cancer	0.000739	0.0134	CbGeAlD
Liotrix—SLC16A10—testis—hematologic cancer	0.000717	0.0129	CbGeAlD
Liotrix—SLC22A8—blood—hematologic cancer	0.000676	0.0122	CbGeAlD
Liotrix—SLCO1A2—lung—hematologic cancer	0.00062	0.0112	CbGeAlD
Liotrix—SLCO4A1—lymph node—hematologic cancer	0.000592	0.0107	CbGeAlD
Liotrix—SLCO1A2—testis—hematologic cancer	0.000585	0.0106	CbGeAlD
Liotrix—ALB—testis—hematologic cancer	0.000582	0.0105	CbGeAlD
Liotrix—SLC16A10—lymph node—hematologic cancer	0.000519	0.00939	CbGeAlD
Liotrix—CYP2C8—blood—hematologic cancer	0.000494	0.00893	CbGeAlD
Liotrix—ALB—lymph node—hematologic cancer	0.000422	0.00762	CbGeAlD
Liotrix—CYP2C8—testis—hematologic cancer	0.000409	0.00739	CbGeAlD
Liotrix—ABCB1—hematopoietic system—hematologic cancer	0.000358	0.00646	CbGeAlD
Liotrix—ABCB1—gonad—hematologic cancer	0.000272	0.00492	CbGeAlD
Liotrix—ABCB1—blood—hematologic cancer	0.000237	0.00428	CbGeAlD
Liotrix—ABCB1—bone marrow—hematologic cancer	0.000229	0.00414	CbGeAlD
Liotrix—ABCB1—lung—hematologic cancer	0.000208	0.00375	CbGeAlD
Liotrix—Levothyroxine—ALB—hematologic cancer	0.000204	0.299	CrCbGaD
Liotrix—ABCB1—testis—hematologic cancer	0.000196	0.00354	CbGeAlD
Liotrix—Levothyroxine—ABCB1—hematologic cancer	0.000195	0.285	CrCbGaD
Liotrix—Liothyronine—ALB—hematologic cancer	0.000145	0.213	CrCbGaD
Liotrix—ABCB1—lymph node—hematologic cancer	0.000142	0.00257	CbGeAlD
Liotrix—Liothyronine—ABCB1—hematologic cancer	0.000139	0.203	CrCbGaD
Liotrix—Vomiting—Mitoxantrone—hematologic cancer	3.07e-05	0.000133	CcSEcCtD
Liotrix—Nausea—Alitretinoin—hematologic cancer	3.06e-05	0.000132	CcSEcCtD
Liotrix—Convulsion—Prednisone—hematologic cancer	3.06e-05	0.000132	CcSEcCtD
Liotrix—Hypertension—Prednisone—hematologic cancer	3.05e-05	0.000132	CcSEcCtD
Liotrix—Rash—Mitoxantrone—hematologic cancer	3.05e-05	0.000132	CcSEcCtD
Liotrix—Rash—Irinotecan—hematologic cancer	3.05e-05	0.000132	CcSEcCtD
Liotrix—Dermatitis—Irinotecan—hematologic cancer	3.04e-05	0.000132	CcSEcCtD
Liotrix—Dermatitis—Mitoxantrone—hematologic cancer	3.04e-05	0.000132	CcSEcCtD
Liotrix—Headache—Irinotecan—hematologic cancer	3.03e-05	0.000131	CcSEcCtD
Liotrix—Headache—Mitoxantrone—hematologic cancer	3.03e-05	0.000131	CcSEcCtD
Liotrix—Nausea—Ifosfamide—hematologic cancer	3.02e-05	0.000131	CcSEcCtD
Liotrix—Musculoskeletal discomfort—Betamethasone—hematologic cancer	3.01e-05	0.00013	CcSEcCtD
Liotrix—Musculoskeletal discomfort—Dexamethasone—hematologic cancer	3.01e-05	0.00013	CcSEcCtD
Liotrix—Arthralgia—Prednisone—hematologic cancer	3e-05	0.00013	CcSEcCtD
Liotrix—Feeling abnormal—Triamcinolone—hematologic cancer	3e-05	0.00013	CcSEcCtD
Liotrix—Diarrhoea—Cisplatin—hematologic cancer	3e-05	0.00013	CcSEcCtD
Liotrix—Anxiety—Prednisone—hematologic cancer	2.99e-05	0.00013	CcSEcCtD
Liotrix—Alopecia—Methotrexate—hematologic cancer	2.99e-05	0.00013	CcSEcCtD
Liotrix—Vomiting—Gemcitabine—hematologic cancer	2.99e-05	0.000129	CcSEcCtD
Liotrix—Insomnia—Betamethasone—hematologic cancer	2.99e-05	0.000129	CcSEcCtD
Liotrix—Insomnia—Dexamethasone—hematologic cancer	2.99e-05	0.000129	CcSEcCtD
Liotrix—Paraesthesia—Betamethasone—hematologic cancer	2.97e-05	0.000129	CcSEcCtD
Liotrix—Paraesthesia—Dexamethasone—hematologic cancer	2.97e-05	0.000129	CcSEcCtD
Liotrix—Rash—Gemcitabine—hematologic cancer	2.97e-05	0.000128	CcSEcCtD
Liotrix—Dermatitis—Gemcitabine—hematologic cancer	2.96e-05	0.000128	CcSEcCtD
Liotrix—Hypersensitivity—Etoposide—hematologic cancer	2.96e-05	0.000128	CcSEcCtD
Liotrix—Headache—Gemcitabine—hematologic cancer	2.95e-05	0.000128	CcSEcCtD
Liotrix—Nausea—Vincristine—hematologic cancer	2.95e-05	0.000128	CcSEcCtD
Liotrix—Flushing—Epirubicin—hematologic cancer	2.94e-05	0.000127	CcSEcCtD
Liotrix—Hypersensitivity—Prednisolone—hematologic cancer	2.92e-05	0.000126	CcSEcCtD
Liotrix—Hypoaesthesia—Doxorubicin—hematologic cancer	2.92e-05	0.000126	CcSEcCtD
Liotrix—Urticaria—Triamcinolone—hematologic cancer	2.9e-05	0.000125	CcSEcCtD
Liotrix—Dysgeusia—Methotrexate—hematologic cancer	2.89e-05	0.000125	CcSEcCtD
Liotrix—Asthenia—Etoposide—hematologic cancer	2.88e-05	0.000125	CcSEcCtD
Liotrix—Body temperature increased—Triamcinolone—hematologic cancer	2.88e-05	0.000125	CcSEcCtD
Liotrix—Oedema—Prednisone—hematologic cancer	2.88e-05	0.000125	CcSEcCtD
Liotrix—Anaphylactic shock—Prednisone—hematologic cancer	2.88e-05	0.000125	CcSEcCtD
Liotrix—Decreased appetite—Betamethasone—hematologic cancer	2.88e-05	0.000124	CcSEcCtD
Liotrix—Decreased appetite—Dexamethasone—hematologic cancer	2.88e-05	0.000124	CcSEcCtD
Liotrix—Nausea—Irinotecan—hematologic cancer	2.87e-05	0.000124	CcSEcCtD
Liotrix—Nausea—Mitoxantrone—hematologic cancer	2.87e-05	0.000124	CcSEcCtD
Liotrix—Infection—Prednisone—hematologic cancer	2.86e-05	0.000124	CcSEcCtD
Liotrix—Fatigue—Betamethasone—hematologic cancer	2.85e-05	0.000123	CcSEcCtD
Liotrix—Fatigue—Dexamethasone—hematologic cancer	2.85e-05	0.000123	CcSEcCtD
Liotrix—Pruritus—Etoposide—hematologic cancer	2.84e-05	0.000123	CcSEcCtD
Liotrix—Shock—Prednisone—hematologic cancer	2.83e-05	0.000123	CcSEcCtD
Liotrix—Arrhythmia—Epirubicin—hematologic cancer	2.83e-05	0.000123	CcSEcCtD
Liotrix—Tachycardia—Prednisone—hematologic cancer	2.81e-05	0.000122	CcSEcCtD
Liotrix—Alopecia—Epirubicin—hematologic cancer	2.8e-05	0.000121	CcSEcCtD
Liotrix—Nausea—Gemcitabine—hematologic cancer	2.8e-05	0.000121	CcSEcCtD
Liotrix—Vomiting—Cisplatin—hematologic cancer	2.79e-05	0.000121	CcSEcCtD
Liotrix—Hyperhidrosis—Prednisone—hematologic cancer	2.78e-05	0.00012	CcSEcCtD
Liotrix—Vision blurred—Methotrexate—hematologic cancer	2.78e-05	0.00012	CcSEcCtD
Liotrix—Rash—Cisplatin—hematologic cancer	2.77e-05	0.00012	CcSEcCtD
Liotrix—Dermatitis—Cisplatin—hematologic cancer	2.76e-05	0.00012	CcSEcCtD
Liotrix—Diarrhoea—Etoposide—hematologic cancer	2.75e-05	0.000119	CcSEcCtD
Liotrix—Anorexia—Prednisone—hematologic cancer	2.75e-05	0.000119	CcSEcCtD
Liotrix—Feeling abnormal—Betamethasone—hematologic cancer	2.73e-05	0.000118	CcSEcCtD
Liotrix—Feeling abnormal—Dexamethasone—hematologic cancer	2.73e-05	0.000118	CcSEcCtD
Liotrix—Flushing—Doxorubicin—hematologic cancer	2.72e-05	0.000118	CcSEcCtD
Liotrix—Flatulence—Epirubicin—hematologic cancer	2.72e-05	0.000118	CcSEcCtD
Liotrix—Tension—Epirubicin—hematologic cancer	2.71e-05	0.000117	CcSEcCtD
Liotrix—Gastrointestinal pain—Betamethasone—hematologic cancer	2.7e-05	0.000117	CcSEcCtD
Liotrix—Gastrointestinal pain—Dexamethasone—hematologic cancer	2.7e-05	0.000117	CcSEcCtD
Liotrix—Dysgeusia—Epirubicin—hematologic cancer	2.7e-05	0.000117	CcSEcCtD
Liotrix—Hypersensitivity—Triamcinolone—hematologic cancer	2.69e-05	0.000116	CcSEcCtD
Liotrix—Nervousness—Epirubicin—hematologic cancer	2.68e-05	0.000116	CcSEcCtD
Liotrix—Dizziness—Etoposide—hematologic cancer	2.66e-05	0.000115	CcSEcCtD
Liotrix—Urticaria—Dexamethasone—hematologic cancer	2.63e-05	0.000114	CcSEcCtD
Liotrix—Urticaria—Betamethasone—hematologic cancer	2.63e-05	0.000114	CcSEcCtD
Liotrix—Musculoskeletal discomfort—Prednisone—hematologic cancer	2.62e-05	0.000114	CcSEcCtD
Liotrix—Dizziness—Prednisolone—hematologic cancer	2.62e-05	0.000113	CcSEcCtD
Liotrix—Arrhythmia—Doxorubicin—hematologic cancer	2.62e-05	0.000113	CcSEcCtD
Liotrix—Asthenia—Triamcinolone—hematologic cancer	2.62e-05	0.000113	CcSEcCtD
Liotrix—Abdominal pain—Betamethasone—hematologic cancer	2.61e-05	0.000113	CcSEcCtD
Liotrix—Body temperature increased—Betamethasone—hematologic cancer	2.61e-05	0.000113	CcSEcCtD
Liotrix—Abdominal pain—Dexamethasone—hematologic cancer	2.61e-05	0.000113	CcSEcCtD
Liotrix—Body temperature increased—Dexamethasone—hematologic cancer	2.61e-05	0.000113	CcSEcCtD
Liotrix—Nausea—Cisplatin—hematologic cancer	2.61e-05	0.000113	CcSEcCtD
Liotrix—Insomnia—Prednisone—hematologic cancer	2.61e-05	0.000113	CcSEcCtD
Liotrix—Vision blurred—Epirubicin—hematologic cancer	2.6e-05	0.000113	CcSEcCtD
Liotrix—Alopecia—Doxorubicin—hematologic cancer	2.59e-05	0.000112	CcSEcCtD
Liotrix—Paraesthesia—Prednisone—hematologic cancer	2.59e-05	0.000112	CcSEcCtD
Liotrix—Pruritus—Triamcinolone—hematologic cancer	2.58e-05	0.000112	CcSEcCtD
Liotrix—Convulsion—Methotrexate—hematologic cancer	2.56e-05	0.000111	CcSEcCtD
Liotrix—Vomiting—Etoposide—hematologic cancer	2.56e-05	0.000111	CcSEcCtD
Liotrix—Agitation—Epirubicin—hematologic cancer	2.54e-05	0.00011	CcSEcCtD
Liotrix—Rash—Etoposide—hematologic cancer	2.53e-05	0.00011	CcSEcCtD
Liotrix—Dermatitis—Etoposide—hematologic cancer	2.53e-05	0.00011	CcSEcCtD
Liotrix—Headache—Etoposide—hematologic cancer	2.52e-05	0.000109	CcSEcCtD
Liotrix—Flatulence—Doxorubicin—hematologic cancer	2.52e-05	0.000109	CcSEcCtD
Liotrix—Arthralgia—Methotrexate—hematologic cancer	2.51e-05	0.000109	CcSEcCtD
Liotrix—Chest pain—Methotrexate—hematologic cancer	2.51e-05	0.000109	CcSEcCtD
Liotrix—Tension—Doxorubicin—hematologic cancer	2.51e-05	0.000108	CcSEcCtD
Liotrix—Decreased appetite—Prednisone—hematologic cancer	2.5e-05	0.000108	CcSEcCtD
Liotrix—Dysgeusia—Doxorubicin—hematologic cancer	2.5e-05	0.000108	CcSEcCtD
Liotrix—Rash—Prednisolone—hematologic cancer	2.5e-05	0.000108	CcSEcCtD
Liotrix—Dermatitis—Prednisolone—hematologic cancer	2.5e-05	0.000108	CcSEcCtD
Liotrix—Fatigue—Prednisone—hematologic cancer	2.48e-05	0.000107	CcSEcCtD
Liotrix—Headache—Prednisolone—hematologic cancer	2.48e-05	0.000107	CcSEcCtD
Liotrix—Nervousness—Doxorubicin—hematologic cancer	2.48e-05	0.000107	CcSEcCtD
Liotrix—Syncope—Epirubicin—hematologic cancer	2.48e-05	0.000107	CcSEcCtD
Liotrix—Constipation—Prednisone—hematologic cancer	2.46e-05	0.000107	CcSEcCtD
Liotrix—Palpitations—Epirubicin—hematologic cancer	2.44e-05	0.000106	CcSEcCtD
Liotrix—Confusional state—Methotrexate—hematologic cancer	2.43e-05	0.000105	CcSEcCtD
Liotrix—Loss of consciousness—Epirubicin—hematologic cancer	2.43e-05	0.000105	CcSEcCtD
Liotrix—Dizziness—Triamcinolone—hematologic cancer	2.41e-05	0.000104	CcSEcCtD
Liotrix—Anaphylactic shock—Methotrexate—hematologic cancer	2.41e-05	0.000104	CcSEcCtD
Liotrix—Vision blurred—Doxorubicin—hematologic cancer	2.41e-05	0.000104	CcSEcCtD
Liotrix—Convulsion—Epirubicin—hematologic cancer	2.39e-05	0.000103	CcSEcCtD
Liotrix—Infection—Methotrexate—hematologic cancer	2.39e-05	0.000103	CcSEcCtD
Liotrix—Nausea—Etoposide—hematologic cancer	2.39e-05	0.000103	CcSEcCtD
Liotrix—Hypertension—Epirubicin—hematologic cancer	2.38e-05	0.000103	CcSEcCtD
Liotrix—Feeling abnormal—Prednisone—hematologic cancer	2.37e-05	0.000103	CcSEcCtD
Liotrix—Asthenia—Dexamethasone—hematologic cancer	2.37e-05	0.000103	CcSEcCtD
Liotrix—Asthenia—Betamethasone—hematologic cancer	2.37e-05	0.000103	CcSEcCtD
Liotrix—Gastrointestinal pain—Prednisone—hematologic cancer	2.36e-05	0.000102	CcSEcCtD
Liotrix—Nausea—Prednisolone—hematologic cancer	2.35e-05	0.000102	CcSEcCtD
Liotrix—Arthralgia—Epirubicin—hematologic cancer	2.35e-05	0.000102	CcSEcCtD
Liotrix—Chest pain—Epirubicin—hematologic cancer	2.35e-05	0.000102	CcSEcCtD
Liotrix—Agitation—Doxorubicin—hematologic cancer	2.35e-05	0.000102	CcSEcCtD
Liotrix—Anxiety—Epirubicin—hematologic cancer	2.34e-05	0.000101	CcSEcCtD
Liotrix—Pruritus—Betamethasone—hematologic cancer	2.34e-05	0.000101	CcSEcCtD
Liotrix—Pruritus—Dexamethasone—hematologic cancer	2.34e-05	0.000101	CcSEcCtD
Liotrix—Hyperhidrosis—Methotrexate—hematologic cancer	2.33e-05	0.000101	CcSEcCtD
Liotrix—Vomiting—Triamcinolone—hematologic cancer	2.32e-05	0.0001	CcSEcCtD
Liotrix—Rash—Triamcinolone—hematologic cancer	2.3e-05	9.95e-05	CcSEcCtD
Liotrix—Dermatitis—Triamcinolone—hematologic cancer	2.3e-05	9.94e-05	CcSEcCtD
Liotrix—Anorexia—Methotrexate—hematologic cancer	2.29e-05	9.93e-05	CcSEcCtD
Liotrix—Syncope—Doxorubicin—hematologic cancer	2.29e-05	9.91e-05	CcSEcCtD
Liotrix—Urticaria—Prednisone—hematologic cancer	2.29e-05	9.9e-05	CcSEcCtD
Liotrix—Headache—Triamcinolone—hematologic cancer	2.28e-05	9.88e-05	CcSEcCtD
Liotrix—Body temperature increased—Prednisone—hematologic cancer	2.28e-05	9.85e-05	CcSEcCtD
Liotrix—Abdominal pain—Prednisone—hematologic cancer	2.28e-05	9.85e-05	CcSEcCtD
Liotrix—Confusional state—Epirubicin—hematologic cancer	2.27e-05	9.83e-05	CcSEcCtD
Liotrix—Diarrhoea—Dexamethasone—hematologic cancer	2.26e-05	9.79e-05	CcSEcCtD
Liotrix—Diarrhoea—Betamethasone—hematologic cancer	2.26e-05	9.79e-05	CcSEcCtD
Liotrix—Palpitations—Doxorubicin—hematologic cancer	2.26e-05	9.77e-05	CcSEcCtD
Liotrix—Anaphylactic shock—Epirubicin—hematologic cancer	2.25e-05	9.75e-05	CcSEcCtD
Liotrix—Oedema—Epirubicin—hematologic cancer	2.25e-05	9.75e-05	CcSEcCtD
Liotrix—Hypotension—Methotrexate—hematologic cancer	2.25e-05	9.73e-05	CcSEcCtD
Liotrix—Loss of consciousness—Doxorubicin—hematologic cancer	2.24e-05	9.71e-05	CcSEcCtD
Liotrix—Infection—Epirubicin—hematologic cancer	2.24e-05	9.68e-05	CcSEcCtD
Liotrix—Shock—Epirubicin—hematologic cancer	2.22e-05	9.59e-05	CcSEcCtD
Liotrix—Convulsion—Doxorubicin—hematologic cancer	2.21e-05	9.58e-05	CcSEcCtD
Liotrix—Hypertension—Doxorubicin—hematologic cancer	2.21e-05	9.54e-05	CcSEcCtD
Liotrix—Tachycardia—Epirubicin—hematologic cancer	2.2e-05	9.51e-05	CcSEcCtD
Liotrix—Musculoskeletal discomfort—Methotrexate—hematologic cancer	2.19e-05	9.49e-05	CcSEcCtD
Liotrix—Dizziness—Dexamethasone—hematologic cancer	2.19e-05	9.46e-05	CcSEcCtD
Liotrix—Dizziness—Betamethasone—hematologic cancer	2.19e-05	9.46e-05	CcSEcCtD
Liotrix—Hyperhidrosis—Epirubicin—hematologic cancer	2.18e-05	9.42e-05	CcSEcCtD
Liotrix—Insomnia—Methotrexate—hematologic cancer	2.18e-05	9.42e-05	CcSEcCtD
Liotrix—Arthralgia—Doxorubicin—hematologic cancer	2.17e-05	9.41e-05	CcSEcCtD
Liotrix—Chest pain—Doxorubicin—hematologic cancer	2.17e-05	9.41e-05	CcSEcCtD
Liotrix—Anxiety—Doxorubicin—hematologic cancer	2.17e-05	9.38e-05	CcSEcCtD
Liotrix—Nausea—Triamcinolone—hematologic cancer	2.17e-05	9.37e-05	CcSEcCtD
Liotrix—Paraesthesia—Methotrexate—hematologic cancer	2.16e-05	9.35e-05	CcSEcCtD
Liotrix—Anorexia—Epirubicin—hematologic cancer	2.15e-05	9.29e-05	CcSEcCtD
Liotrix—Dyspnoea—Methotrexate—hematologic cancer	2.15e-05	9.29e-05	CcSEcCtD
Liotrix—Hypersensitivity—Prednisone—hematologic cancer	2.12e-05	9.18e-05	CcSEcCtD
Liotrix—Hypotension—Epirubicin—hematologic cancer	2.11e-05	9.11e-05	CcSEcCtD
Liotrix—Vomiting—Dexamethasone—hematologic cancer	2.1e-05	9.1e-05	CcSEcCtD
Liotrix—Vomiting—Betamethasone—hematologic cancer	2.1e-05	9.1e-05	CcSEcCtD
Liotrix—Confusional state—Doxorubicin—hematologic cancer	2.1e-05	9.09e-05	CcSEcCtD
Liotrix—Decreased appetite—Methotrexate—hematologic cancer	2.09e-05	9.05e-05	CcSEcCtD
Liotrix—Rash—Dexamethasone—hematologic cancer	2.09e-05	9.02e-05	CcSEcCtD
Liotrix—Rash—Betamethasone—hematologic cancer	2.09e-05	9.02e-05	CcSEcCtD
Liotrix—Anaphylactic shock—Doxorubicin—hematologic cancer	2.08e-05	9.02e-05	CcSEcCtD
Liotrix—Oedema—Doxorubicin—hematologic cancer	2.08e-05	9.02e-05	CcSEcCtD
Liotrix—Dermatitis—Betamethasone—hematologic cancer	2.08e-05	9.02e-05	CcSEcCtD
Liotrix—Dermatitis—Dexamethasone—hematologic cancer	2.08e-05	9.02e-05	CcSEcCtD
Liotrix—Fatigue—Methotrexate—hematologic cancer	2.08e-05	8.98e-05	CcSEcCtD
Liotrix—Headache—Dexamethasone—hematologic cancer	2.07e-05	8.97e-05	CcSEcCtD
Liotrix—Headache—Betamethasone—hematologic cancer	2.07e-05	8.97e-05	CcSEcCtD
Liotrix—Infection—Doxorubicin—hematologic cancer	2.07e-05	8.96e-05	CcSEcCtD
Liotrix—Asthenia—Prednisone—hematologic cancer	2.07e-05	8.94e-05	CcSEcCtD
Liotrix—Musculoskeletal discomfort—Epirubicin—hematologic cancer	2.05e-05	8.88e-05	CcSEcCtD
Liotrix—Shock—Doxorubicin—hematologic cancer	2.05e-05	8.87e-05	CcSEcCtD
Liotrix—Pruritus—Prednisone—hematologic cancer	2.04e-05	8.82e-05	CcSEcCtD
Liotrix—Insomnia—Epirubicin—hematologic cancer	2.04e-05	8.82e-05	CcSEcCtD
Liotrix—Tachycardia—Doxorubicin—hematologic cancer	2.03e-05	8.8e-05	CcSEcCtD
Liotrix—Paraesthesia—Epirubicin—hematologic cancer	2.02e-05	8.75e-05	CcSEcCtD
Liotrix—Hyperhidrosis—Doxorubicin—hematologic cancer	2.02e-05	8.72e-05	CcSEcCtD
Liotrix—Dyspnoea—Epirubicin—hematologic cancer	2.01e-05	8.69e-05	CcSEcCtD
Liotrix—Anorexia—Doxorubicin—hematologic cancer	1.99e-05	8.6e-05	CcSEcCtD
Liotrix—Feeling abnormal—Methotrexate—hematologic cancer	1.98e-05	8.58e-05	CcSEcCtD
Liotrix—Diarrhoea—Prednisone—hematologic cancer	1.97e-05	8.53e-05	CcSEcCtD
Liotrix—Gastrointestinal pain—Methotrexate—hematologic cancer	1.97e-05	8.52e-05	CcSEcCtD
Liotrix—Nausea—Dexamethasone—hematologic cancer	1.96e-05	8.5e-05	CcSEcCtD
Liotrix—Nausea—Betamethasone—hematologic cancer	1.96e-05	8.5e-05	CcSEcCtD
Liotrix—Decreased appetite—Epirubicin—hematologic cancer	1.96e-05	8.47e-05	CcSEcCtD
Liotrix—Hypotension—Doxorubicin—hematologic cancer	1.95e-05	8.43e-05	CcSEcCtD
Liotrix—Fatigue—Epirubicin—hematologic cancer	1.94e-05	8.4e-05	CcSEcCtD
Liotrix—Constipation—Epirubicin—hematologic cancer	1.93e-05	8.34e-05	CcSEcCtD
Liotrix—Urticaria—Methotrexate—hematologic cancer	1.91e-05	8.27e-05	CcSEcCtD
Liotrix—Dizziness—Prednisone—hematologic cancer	1.9e-05	8.24e-05	CcSEcCtD
Liotrix—Body temperature increased—Methotrexate—hematologic cancer	1.9e-05	8.23e-05	CcSEcCtD
Liotrix—Abdominal pain—Methotrexate—hematologic cancer	1.9e-05	8.23e-05	CcSEcCtD
Liotrix—Musculoskeletal discomfort—Doxorubicin—hematologic cancer	1.9e-05	8.22e-05	CcSEcCtD
Liotrix—Insomnia—Doxorubicin—hematologic cancer	1.89e-05	8.16e-05	CcSEcCtD
Liotrix—Paraesthesia—Doxorubicin—hematologic cancer	1.87e-05	8.1e-05	CcSEcCtD
Liotrix—Dyspnoea—Doxorubicin—hematologic cancer	1.86e-05	8.04e-05	CcSEcCtD
Liotrix—Feeling abnormal—Epirubicin—hematologic cancer	1.86e-05	8.03e-05	CcSEcCtD
Liotrix—Gastrointestinal pain—Epirubicin—hematologic cancer	1.84e-05	7.97e-05	CcSEcCtD
Liotrix—Vomiting—Prednisone—hematologic cancer	1.83e-05	7.92e-05	CcSEcCtD
Liotrix—Rash—Prednisone—hematologic cancer	1.82e-05	7.86e-05	CcSEcCtD
Liotrix—Dermatitis—Prednisone—hematologic cancer	1.81e-05	7.85e-05	CcSEcCtD
Liotrix—Decreased appetite—Doxorubicin—hematologic cancer	1.81e-05	7.84e-05	CcSEcCtD
Liotrix—Headache—Prednisone—hematologic cancer	1.8e-05	7.81e-05	CcSEcCtD
Liotrix—Fatigue—Doxorubicin—hematologic cancer	1.8e-05	7.78e-05	CcSEcCtD
Liotrix—Urticaria—Epirubicin—hematologic cancer	1.79e-05	7.74e-05	CcSEcCtD
Liotrix—Constipation—Doxorubicin—hematologic cancer	1.78e-05	7.71e-05	CcSEcCtD
Liotrix—Body temperature increased—Epirubicin—hematologic cancer	1.78e-05	7.71e-05	CcSEcCtD
Liotrix—Abdominal pain—Epirubicin—hematologic cancer	1.78e-05	7.71e-05	CcSEcCtD
Liotrix—Hypersensitivity—Methotrexate—hematologic cancer	1.77e-05	7.67e-05	CcSEcCtD
Liotrix—Asthenia—Methotrexate—hematologic cancer	1.73e-05	7.47e-05	CcSEcCtD
Liotrix—Feeling abnormal—Doxorubicin—hematologic cancer	1.72e-05	7.43e-05	CcSEcCtD
Liotrix—Nausea—Prednisone—hematologic cancer	1.71e-05	7.4e-05	CcSEcCtD
Liotrix—Gastrointestinal pain—Doxorubicin—hematologic cancer	1.7e-05	7.38e-05	CcSEcCtD
Liotrix—Pruritus—Methotrexate—hematologic cancer	1.7e-05	7.37e-05	CcSEcCtD
Liotrix—Hypersensitivity—Epirubicin—hematologic cancer	1.66e-05	7.18e-05	CcSEcCtD
Liotrix—Urticaria—Doxorubicin—hematologic cancer	1.66e-05	7.17e-05	CcSEcCtD
Liotrix—Abdominal pain—Doxorubicin—hematologic cancer	1.65e-05	7.13e-05	CcSEcCtD
Liotrix—Body temperature increased—Doxorubicin—hematologic cancer	1.65e-05	7.13e-05	CcSEcCtD
Liotrix—Diarrhoea—Methotrexate—hematologic cancer	1.65e-05	7.13e-05	CcSEcCtD
Liotrix—Asthenia—Epirubicin—hematologic cancer	1.62e-05	6.99e-05	CcSEcCtD
Liotrix—Pruritus—Epirubicin—hematologic cancer	1.59e-05	6.9e-05	CcSEcCtD
Liotrix—Dizziness—Methotrexate—hematologic cancer	1.59e-05	6.89e-05	CcSEcCtD
Liotrix—Diarrhoea—Epirubicin—hematologic cancer	1.54e-05	6.67e-05	CcSEcCtD
Liotrix—Hypersensitivity—Doxorubicin—hematologic cancer	1.54e-05	6.65e-05	CcSEcCtD
Liotrix—Vomiting—Methotrexate—hematologic cancer	1.53e-05	6.62e-05	CcSEcCtD
Liotrix—Rash—Methotrexate—hematologic cancer	1.52e-05	6.57e-05	CcSEcCtD
Liotrix—Dermatitis—Methotrexate—hematologic cancer	1.52e-05	6.56e-05	CcSEcCtD
Liotrix—Headache—Methotrexate—hematologic cancer	1.51e-05	6.53e-05	CcSEcCtD
Liotrix—Asthenia—Doxorubicin—hematologic cancer	1.5e-05	6.47e-05	CcSEcCtD
Liotrix—Dizziness—Epirubicin—hematologic cancer	1.49e-05	6.45e-05	CcSEcCtD
Liotrix—Pruritus—Doxorubicin—hematologic cancer	1.47e-05	6.38e-05	CcSEcCtD
Liotrix—Vomiting—Epirubicin—hematologic cancer	1.43e-05	6.2e-05	CcSEcCtD
Liotrix—Nausea—Methotrexate—hematologic cancer	1.43e-05	6.19e-05	CcSEcCtD
Liotrix—Diarrhoea—Doxorubicin—hematologic cancer	1.43e-05	6.17e-05	CcSEcCtD
Liotrix—Rash—Epirubicin—hematologic cancer	1.42e-05	6.15e-05	CcSEcCtD
Liotrix—Dermatitis—Epirubicin—hematologic cancer	1.42e-05	6.14e-05	CcSEcCtD
Liotrix—Headache—Epirubicin—hematologic cancer	1.41e-05	6.11e-05	CcSEcCtD
Liotrix—Dizziness—Doxorubicin—hematologic cancer	1.38e-05	5.96e-05	CcSEcCtD
Liotrix—Nausea—Epirubicin—hematologic cancer	1.34e-05	5.79e-05	CcSEcCtD
Liotrix—Vomiting—Doxorubicin—hematologic cancer	1.33e-05	5.73e-05	CcSEcCtD
Liotrix—Rash—Doxorubicin—hematologic cancer	1.31e-05	5.69e-05	CcSEcCtD
Liotrix—Dermatitis—Doxorubicin—hematologic cancer	1.31e-05	5.68e-05	CcSEcCtD
Liotrix—Headache—Doxorubicin—hematologic cancer	1.31e-05	5.65e-05	CcSEcCtD
Liotrix—Nausea—Doxorubicin—hematologic cancer	1.24e-05	5.36e-05	CcSEcCtD
Liotrix—TTR—Signaling Pathways—JAK2—hematologic cancer	6.4e-06	6.63e-05	CbGpPWpGaD
Liotrix—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—hematologic cancer	6.35e-06	6.59e-05	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—IDH2—hematologic cancer	6.33e-06	6.57e-05	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—HMMR—hematologic cancer	6.33e-06	6.57e-05	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—IDH1—hematologic cancer	6.25e-06	6.48e-05	CbGpPWpGaD
Liotrix—ALB—Hemostasis—CDK2—hematologic cancer	6.25e-06	6.48e-05	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—MDM2—hematologic cancer	6.24e-06	6.47e-05	CbGpPWpGaD
Liotrix—TTR—Disease—MYC—hematologic cancer	6.23e-06	6.46e-05	CbGpPWpGaD
Liotrix—ALB—Metabolism—IDH1—hematologic cancer	6.22e-06	6.44e-05	CbGpPWpGaD
Liotrix—TTR—Disease—TGFB1—hematologic cancer	6.21e-06	6.44e-05	CbGpPWpGaD
Liotrix—SLCO1A2—Metabolism—GSTM1—hematologic cancer	6.21e-06	6.44e-05	CbGpPWpGaD
Liotrix—SLCO1A2—Metabolism—NCOR1—hematologic cancer	6.21e-06	6.44e-05	CbGpPWpGaD
Liotrix—SLC10A1—Metabolism—PTEN—hematologic cancer	6.21e-06	6.44e-05	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—ABCC3—hematologic cancer	6.18e-06	6.41e-05	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—TXN—hematologic cancer	6.18e-06	6.41e-05	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—GSTO1—hematologic cancer	6.18e-06	6.41e-05	CbGpPWpGaD
Liotrix—SLCO1B3—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	6.16e-06	6.39e-05	CbGpPWpGaD
Liotrix—ALB—Metabolism—TXN—hematologic cancer	6.15e-06	6.37e-05	CbGpPWpGaD
Liotrix—ALB—Metabolism—ABCC3—hematologic cancer	6.15e-06	6.37e-05	CbGpPWpGaD
Liotrix—ALB—Metabolism—GSTO1—hematologic cancer	6.15e-06	6.37e-05	CbGpPWpGaD
Liotrix—ALB—Platelet activation, signaling and aggregation—MAPK3—hematologic cancer	6.1e-06	6.33e-05	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—MTOR—hematologic cancer	6.08e-06	6.3e-05	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—PIK3CB—hematologic cancer	6.08e-06	6.3e-05	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—SPHK1—hematologic cancer	6.05e-06	6.27e-05	CbGpPWpGaD
Liotrix—ALB—Metabolism—SPHK1—hematologic cancer	6.01e-06	6.24e-05	CbGpPWpGaD
Liotrix—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—hematologic cancer	6.01e-06	6.23e-05	CbGpPWpGaD
Liotrix—ALB—Hemostasis—MAPK14—hematologic cancer	5.99e-06	6.22e-05	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—ARNTL—hematologic cancer	5.95e-06	6.17e-05	CbGpPWpGaD
Liotrix—SLC10A1—Metabolism—EP300—hematologic cancer	5.92e-06	6.14e-05	CbGpPWpGaD
Liotrix—ALB—Platelet activation, signaling and aggregation—TGFB1—hematologic cancer	5.92e-06	6.14e-05	CbGpPWpGaD
Liotrix—SLCO1B3—Metabolism—PIK3CG—hematologic cancer	5.87e-06	6.09e-05	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	5.87e-06	6.08e-05	CbGpPWpGaD
Liotrix—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—hematologic cancer	5.84e-06	6.06e-05	CbGpPWpGaD
Liotrix—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—hematologic cancer	5.83e-06	6.04e-05	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—UGT1A1—hematologic cancer	5.81e-06	6.03e-05	CbGpPWpGaD
Liotrix—ALB—Hemostasis—FN1—hematologic cancer	5.81e-06	6.02e-05	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—CA9—hematologic cancer	5.79e-06	6.01e-05	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—ACP5—hematologic cancer	5.79e-06	6.01e-05	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism—GSTP1—hematologic cancer	5.78e-06	5.99e-05	CbGpPWpGaD
Liotrix—ALB—Metabolism—UGT1A1—hematologic cancer	5.78e-06	5.99e-05	CbGpPWpGaD
Liotrix—TTR—Disease—KRAS—hematologic cancer	5.76e-06	5.97e-05	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—NCOR2—hematologic cancer	5.72e-06	5.93e-05	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—CDKN1B—hematologic cancer	5.7e-06	5.91e-05	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—SLC22A1—hematologic cancer	5.65e-06	5.86e-05	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—CRABP1—hematologic cancer	5.65e-06	5.86e-05	CbGpPWpGaD
Liotrix—ALB—Metabolism—SLC22A1—hematologic cancer	5.62e-06	5.83e-05	CbGpPWpGaD
Liotrix—ALB—Metabolism—CRABP1—hematologic cancer	5.62e-06	5.83e-05	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	5.59e-06	5.8e-05	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—CASP3—hematologic cancer	5.59e-06	5.79e-05	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—IL2—hematologic cancer	5.58e-06	5.79e-05	CbGpPWpGaD
Liotrix—ALB—Hemostasis—PIK3CG—hematologic cancer	5.56e-06	5.76e-05	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—ALOX5—hematologic cancer	5.51e-06	5.71e-05	CbGpPWpGaD
Liotrix—SLCO1A2—Metabolism—MTHFR—hematologic cancer	5.49e-06	5.69e-05	CbGpPWpGaD
Liotrix—ALB—Metabolism—ALOX5—hematologic cancer	5.48e-06	5.68e-05	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism—ABCB1—hematologic cancer	5.47e-06	5.67e-05	CbGpPWpGaD
Liotrix—ALB—Hemostasis—PTPN11—hematologic cancer	5.46e-06	5.66e-05	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—IDH1—hematologic cancer	5.45e-06	5.65e-05	CbGpPWpGaD
Liotrix—SLCO1B3—Metabolism—CREBBP—hematologic cancer	5.44e-06	5.64e-05	CbGpPWpGaD
Liotrix—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—hematologic cancer	5.44e-06	5.64e-05	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—CCND1—hematologic cancer	5.44e-06	5.64e-05	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—JUN—hematologic cancer	5.43e-06	5.63e-05	CbGpPWpGaD
Liotrix—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—hematologic cancer	5.4e-06	5.6e-05	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—TXN—hematologic cancer	5.38e-06	5.58e-05	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—ABCC3—hematologic cancer	5.38e-06	5.58e-05	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—GSTO1—hematologic cancer	5.38e-06	5.58e-05	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—NUP98—hematologic cancer	5.34e-06	5.53e-05	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism—NCOR1—hematologic cancer	5.31e-06	5.51e-05	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism—GSTM1—hematologic cancer	5.31e-06	5.51e-05	CbGpPWpGaD
Liotrix—ALB—Metabolism—NUP98—hematologic cancer	5.31e-06	5.5e-05	CbGpPWpGaD
Liotrix—TTR—Disease—PIK3CA—hematologic cancer	5.29e-06	5.48e-05	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—SPHK1—hematologic cancer	5.27e-06	5.46e-05	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—CDKN1A—hematologic cancer	5.26e-06	5.46e-05	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—PTEN—hematologic cancer	5.25e-06	5.44e-05	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—ADCY7—hematologic cancer	5.18e-06	5.37e-05	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—NCOA3—hematologic cancer	5.18e-06	5.37e-05	CbGpPWpGaD
Liotrix—SLCO1B3—Metabolism—PIK3CD—hematologic cancer	5.16e-06	5.35e-05	CbGpPWpGaD
Liotrix—ALB—Hemostasis—CREBBP—hematologic cancer	5.15e-06	5.34e-05	CbGpPWpGaD
Liotrix—ALB—Metabolism—ADCY7—hematologic cancer	5.15e-06	5.34e-05	CbGpPWpGaD
Liotrix—ALB—Metabolism—NCOA3—hematologic cancer	5.15e-06	5.34e-05	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—NUP214—hematologic cancer	5.14e-06	5.33e-05	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—MAPK8—hematologic cancer	5.14e-06	5.33e-05	CbGpPWpGaD
Liotrix—ALB—Metabolism—NUP214—hematologic cancer	5.11e-06	5.3e-05	CbGpPWpGaD
Liotrix—SLCO1B3—Metabolism—ALB—hematologic cancer	5.1e-06	5.28e-05	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	5.09e-06	5.28e-05	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—UGT1A1—hematologic cancer	5.06e-06	5.25e-05	CbGpPWpGaD
Liotrix—ALB—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	5.06e-06	5.25e-05	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—MTR—hematologic cancer	5.04e-06	5.22e-05	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—ABCG2—hematologic cancer	5.04e-06	5.22e-05	CbGpPWpGaD
Liotrix—ALB—Platelet activation, signaling and aggregation—PIK3CA—hematologic cancer	5.04e-06	5.22e-05	CbGpPWpGaD
Liotrix—ALB—Metabolism—MTR—hematologic cancer	5.01e-06	5.19e-05	CbGpPWpGaD
Liotrix—ALB—Metabolism—ABCG2—hematologic cancer	5.01e-06	5.19e-05	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—EP300—hematologic cancer	5.01e-06	5.19e-05	CbGpPWpGaD
Liotrix—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—hematologic cancer	4.96e-06	5.14e-05	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—ENO2—hematologic cancer	4.94e-06	5.12e-05	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—SLC22A1—hematologic cancer	4.93e-06	5.11e-05	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—CRABP1—hematologic cancer	4.93e-06	5.11e-05	CbGpPWpGaD
Liotrix—ALB—Metabolism—ENO2—hematologic cancer	4.91e-06	5.09e-05	CbGpPWpGaD
Liotrix—TTR—Disease—HRAS—hematologic cancer	4.89e-06	5.07e-05	CbGpPWpGaD
Liotrix—ALB—Hemostasis—PIK3CD—hematologic cancer	4.89e-06	5.07e-05	CbGpPWpGaD
Liotrix—SLCO1B3—Metabolism—PIK3R1—hematologic cancer	4.87e-06	5.05e-05	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—SRC—hematologic cancer	4.87e-06	5.05e-05	CbGpPWpGaD
Liotrix—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	4.84e-06	5.02e-05	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—ALOX5—hematologic cancer	4.8e-06	4.98e-05	CbGpPWpGaD
Liotrix—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—hematologic cancer	4.8e-06	4.98e-05	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—GSTT1—hematologic cancer	4.79e-06	4.97e-05	CbGpPWpGaD
Liotrix—ALB—Metabolism—GSTT1—hematologic cancer	4.77e-06	4.94e-05	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—VEGFA—hematologic cancer	4.74e-06	4.92e-05	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	4.72e-06	4.89e-05	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism—MTHFR—hematologic cancer	4.7e-06	4.87e-05	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—STAT3—hematologic cancer	4.7e-06	4.87e-05	CbGpPWpGaD
Liotrix—ALB—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	4.69e-06	4.87e-05	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—SDC1—hematologic cancer	4.68e-06	4.86e-05	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—NRAS—hematologic cancer	4.68e-06	4.86e-05	CbGpPWpGaD
Liotrix—TTR—Disease—IL6—hematologic cancer	4.68e-06	4.86e-05	CbGpPWpGaD
Liotrix—ALB—Metabolism—SDC1—hematologic cancer	4.66e-06	4.83e-05	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—NUP98—hematologic cancer	4.65e-06	4.82e-05	CbGpPWpGaD
Liotrix—ALB—Hemostasis—PIK3R1—hematologic cancer	4.61e-06	4.78e-05	CbGpPWpGaD
Liotrix—SLCO1A2—Metabolism—PIK3CG—hematologic cancer	4.61e-06	4.78e-05	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—ADCY7—hematologic cancer	4.51e-06	4.68e-05	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—NCOA3—hematologic cancer	4.51e-06	4.68e-05	CbGpPWpGaD
Liotrix—SLCO1B3—Metabolism—PIK3CB—hematologic cancer	4.5e-06	4.66e-05	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—MAPK3—hematologic cancer	4.49e-06	4.65e-05	CbGpPWpGaD
Liotrix—ALB—Hemostasis—JAK2—hematologic cancer	4.49e-06	4.65e-05	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—NUP214—hematologic cancer	4.48e-06	4.65e-05	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	4.47e-06	4.64e-05	CbGpPWpGaD
Liotrix—ALB—Transmembrane transport of small molecules—CREBBP—hematologic cancer	4.46e-06	4.63e-05	CbGpPWpGaD
Liotrix—ALB—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	4.45e-06	4.61e-05	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	4.42e-06	4.58e-05	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—MTR—hematologic cancer	4.39e-06	4.55e-05	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—ABCG2—hematologic cancer	4.39e-06	4.55e-05	CbGpPWpGaD
Liotrix—SLC10A1—Metabolism—PIK3CA—hematologic cancer	4.38e-06	4.54e-05	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—MYC—hematologic cancer	4.36e-06	4.52e-05	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—TGFB1—hematologic cancer	4.35e-06	4.51e-05	CbGpPWpGaD
Liotrix—TTR—Disease—AKT1—hematologic cancer	4.32e-06	4.48e-05	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—ENO2—hematologic cancer	4.3e-06	4.46e-05	CbGpPWpGaD
Liotrix—SLCO1A2—Metabolism—CREBBP—hematologic cancer	4.28e-06	4.43e-05	CbGpPWpGaD
Liotrix—ALB—Hemostasis—PIK3CB—hematologic cancer	4.26e-06	4.42e-05	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	4.23e-06	4.38e-05	CbGpPWpGaD
Liotrix—ALB—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	4.2e-06	4.36e-05	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—GSTT1—hematologic cancer	4.18e-06	4.33e-05	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	4.14e-06	4.29e-05	CbGpPWpGaD
Liotrix—ALB—Platelet activation, signaling and aggregation—AKT1—hematologic cancer	4.12e-06	4.27e-05	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—SDC1—hematologic cancer	4.08e-06	4.23e-05	CbGpPWpGaD
Liotrix—SLCO1A2—Metabolism—PIK3CD—hematologic cancer	4.06e-06	4.2e-05	CbGpPWpGaD
Liotrix—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—hematologic cancer	4.05e-06	4.2e-05	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—KRAS—hematologic cancer	4.03e-06	4.18e-05	CbGpPWpGaD
Liotrix—SLCO1A2—Metabolism—ALB—hematologic cancer	4e-06	4.15e-05	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—CD44—hematologic cancer	3.98e-06	4.13e-05	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—NQO1—hematologic cancer	3.98e-06	4.13e-05	CbGpPWpGaD
Liotrix—ALB—Metabolism—CD44—hematologic cancer	3.96e-06	4.11e-05	CbGpPWpGaD
Liotrix—ALB—Metabolism—NQO1—hematologic cancer	3.96e-06	4.11e-05	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism—PIK3CG—hematologic cancer	3.94e-06	4.09e-05	CbGpPWpGaD
Liotrix—ALB—Hemostasis—IL2—hematologic cancer	3.91e-06	4.06e-05	CbGpPWpGaD
Liotrix—ABCB1—Transmembrane transport of small molecules—CREBBP—hematologic cancer	3.91e-06	4.05e-05	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	3.9e-06	4.04e-05	CbGpPWpGaD
Liotrix—SLCO1B3—Metabolism—PTEN—hematologic cancer	3.89e-06	4.03e-05	CbGpPWpGaD
Liotrix—ALB—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	3.88e-06	4.02e-05	CbGpPWpGaD
Liotrix—SLCO1A2—Metabolism—PIK3R1—hematologic cancer	3.83e-06	3.97e-05	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—CYCS—hematologic cancer	3.77e-06	3.91e-05	CbGpPWpGaD
Liotrix—ALB—Metabolism—CYCS—hematologic cancer	3.75e-06	3.89e-05	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—HSP90AA1—hematologic cancer	3.74e-06	3.88e-05	CbGpPWpGaD
Liotrix—ALB—Metabolism—HSP90AA1—hematologic cancer	3.72e-06	3.86e-05	CbGpPWpGaD
Liotrix—SLCO1B3—Metabolism—EP300—hematologic cancer	3.71e-06	3.84e-05	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—PIK3CA—hematologic cancer	3.7e-06	3.84e-05	CbGpPWpGaD
Liotrix—ABCB1—Transmembrane transport of small molecules—ALB—hematologic cancer	3.66e-06	3.79e-05	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism—CREBBP—hematologic cancer	3.66e-06	3.79e-05	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—TP53—hematologic cancer	3.58e-06	3.71e-05	CbGpPWpGaD
Liotrix—SLC10A1—Metabolism—AKT1—hematologic cancer	3.58e-06	3.71e-05	CbGpPWpGaD
Liotrix—SLCO1A2—Metabolism—PIK3CB—hematologic cancer	3.53e-06	3.67e-05	CbGpPWpGaD
Liotrix—ALB—Hemostasis—EP300—hematologic cancer	3.51e-06	3.64e-05	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—CD44—hematologic cancer	3.47e-06	3.6e-05	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—NQO1—hematologic cancer	3.47e-06	3.6e-05	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism—PIK3CD—hematologic cancer	3.47e-06	3.6e-05	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—HRAS—hematologic cancer	3.43e-06	3.55e-05	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism—ALB—hematologic cancer	3.42e-06	3.55e-05	CbGpPWpGaD
Liotrix—ALB—Hemostasis—SRC—hematologic cancer	3.41e-06	3.54e-05	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	3.37e-06	3.49e-05	CbGpPWpGaD
Liotrix—ALB—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	3.35e-06	3.47e-05	CbGpPWpGaD
Liotrix—ALB—Hemostasis—VEGFA—hematologic cancer	3.32e-06	3.45e-05	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—GSTP1—hematologic cancer	3.32e-06	3.44e-05	CbGpPWpGaD
Liotrix—ALB—Metabolism—GSTP1—hematologic cancer	3.3e-06	3.43e-05	CbGpPWpGaD
Liotrix—ALB—Hemostasis—NRAS—hematologic cancer	3.28e-06	3.41e-05	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—CYCS—hematologic cancer	3.28e-06	3.4e-05	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—IL6—hematologic cancer	3.28e-06	3.4e-05	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism—PIK3R1—hematologic cancer	3.27e-06	3.4e-05	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—HSP90AA1—hematologic cancer	3.26e-06	3.38e-05	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	3.21e-06	3.33e-05	CbGpPWpGaD
Liotrix—ALB—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	3.2e-06	3.31e-05	CbGpPWpGaD
Liotrix—ALB—Hemostasis—MAPK3—hematologic cancer	3.15e-06	3.26e-05	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—ABCB1—hematologic cancer	3.14e-06	3.26e-05	CbGpPWpGaD
Liotrix—ALB—Metabolism—ABCB1—hematologic cancer	3.13e-06	3.24e-05	CbGpPWpGaD
Liotrix—SLCO1A2—Metabolism—PTEN—hematologic cancer	3.05e-06	3.17e-05	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—NCOR1—hematologic cancer	3.05e-06	3.17e-05	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—GSTM1—hematologic cancer	3.05e-06	3.17e-05	CbGpPWpGaD
Liotrix—ALB—Hemostasis—TGFB1—hematologic cancer	3.05e-06	3.16e-05	CbGpPWpGaD
Liotrix—ALB—Metabolism—NCOR1—hematologic cancer	3.04e-06	3.15e-05	CbGpPWpGaD
Liotrix—ALB—Metabolism—GSTM1—hematologic cancer	3.04e-06	3.15e-05	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—AKT1—hematologic cancer	3.03e-06	3.14e-05	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism—PIK3CB—hematologic cancer	3.02e-06	3.13e-05	CbGpPWpGaD
Liotrix—SLCO1A2—Metabolism—EP300—hematologic cancer	2.91e-06	3.02e-05	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—GSTP1—hematologic cancer	2.89e-06	3e-05	CbGpPWpGaD
Liotrix—ALB—Hemostasis—KRAS—hematologic cancer	2.83e-06	2.93e-05	CbGpPWpGaD
Liotrix—SLCO1B3—Metabolism—PIK3CA—hematologic cancer	2.74e-06	2.84e-05	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—MTHFR—hematologic cancer	2.7e-06	2.8e-05	CbGpPWpGaD
Liotrix—ALB—Metabolism—MTHFR—hematologic cancer	2.68e-06	2.78e-05	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—NCOR1—hematologic cancer	2.66e-06	2.76e-05	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—GSTM1—hematologic cancer	2.66e-06	2.76e-05	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism—PTEN—hematologic cancer	2.61e-06	2.71e-05	CbGpPWpGaD
Liotrix—ALB—Hemostasis—PIK3CA—hematologic cancer	2.6e-06	2.69e-05	CbGpPWpGaD
Liotrix—ALB—Hemostasis—TP53—hematologic cancer	2.51e-06	2.6e-05	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism—EP300—hematologic cancer	2.49e-06	2.58e-05	CbGpPWpGaD
Liotrix—ALB—Hemostasis—HRAS—hematologic cancer	2.4e-06	2.49e-05	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	2.38e-06	2.47e-05	CbGpPWpGaD
Liotrix—ALB—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	2.36e-06	2.45e-05	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—MTHFR—hematologic cancer	2.35e-06	2.44e-05	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—PIK3CG—hematologic cancer	2.27e-06	2.35e-05	CbGpPWpGaD
Liotrix—ALB—Metabolism—PIK3CG—hematologic cancer	2.25e-06	2.34e-05	CbGpPWpGaD
Liotrix—SLCO1B3—Metabolism—AKT1—hematologic cancer	2.24e-06	2.32e-05	CbGpPWpGaD
Liotrix—SLCO1A2—Metabolism—PIK3CA—hematologic cancer	2.15e-06	2.23e-05	CbGpPWpGaD
Liotrix—ALB—Hemostasis—AKT1—hematologic cancer	2.12e-06	2.2e-05	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—CREBBP—hematologic cancer	2.1e-06	2.18e-05	CbGpPWpGaD
Liotrix—ALB—Metabolism—CREBBP—hematologic cancer	2.09e-06	2.17e-05	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—PIK3CD—hematologic cancer	1.99e-06	2.07e-05	CbGpPWpGaD
Liotrix—ALB—Metabolism—PIK3CD—hematologic cancer	1.98e-06	2.05e-05	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—PIK3CG—hematologic cancer	1.97e-06	2.05e-05	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—ALB—hematologic cancer	1.97e-06	2.04e-05	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—PIK3R1—hematologic cancer	1.88e-06	1.95e-05	CbGpPWpGaD
Liotrix—ALB—Metabolism—PIK3R1—hematologic cancer	1.87e-06	1.94e-05	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism—PIK3CA—hematologic cancer	1.84e-06	1.91e-05	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—CREBBP—hematologic cancer	1.83e-06	1.9e-05	CbGpPWpGaD
Liotrix—SLCO1A2—Metabolism—AKT1—hematologic cancer	1.76e-06	1.83e-05	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—PIK3CB—hematologic cancer	1.74e-06	1.8e-05	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—PIK3CD—hematologic cancer	1.74e-06	1.8e-05	CbGpPWpGaD
Liotrix—ALB—Metabolism—PIK3CB—hematologic cancer	1.73e-06	1.79e-05	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—ALB—hematologic cancer	1.71e-06	1.78e-05	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—PIK3R1—hematologic cancer	1.64e-06	1.7e-05	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—PIK3CB—hematologic cancer	1.51e-06	1.57e-05	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism—AKT1—hematologic cancer	1.51e-06	1.56e-05	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—PTEN—hematologic cancer	1.5e-06	1.56e-05	CbGpPWpGaD
Liotrix—ALB—Metabolism—PTEN—hematologic cancer	1.49e-06	1.55e-05	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—EP300—hematologic cancer	1.43e-06	1.48e-05	CbGpPWpGaD
Liotrix—ALB—Metabolism—EP300—hematologic cancer	1.42e-06	1.48e-05	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—PTEN—hematologic cancer	1.31e-06	1.36e-05	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—EP300—hematologic cancer	1.25e-06	1.29e-05	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—PIK3CA—hematologic cancer	1.06e-06	1.1e-05	CbGpPWpGaD
Liotrix—ALB—Metabolism—PIK3CA—hematologic cancer	1.05e-06	1.09e-05	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—PIK3CA—hematologic cancer	9.22e-07	9.57e-06	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—AKT1—hematologic cancer	8.65e-07	8.97e-06	CbGpPWpGaD
Liotrix—ALB—Metabolism—AKT1—hematologic cancer	8.6e-07	8.92e-06	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—AKT1—hematologic cancer	7.54e-07	7.81e-06	CbGpPWpGaD
